Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Time to Endorse A Sensitive Method for Scoring Endoscopic Activity of Ulcerative Colitis in Clinical Research.
Journal: Journal of Crohn's & colitis
Published: August 24, 2022
Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 22, 2019
Drug-Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: August 10, 2018
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.
Journal: European journal of clinical pharmacology
Published: August 08, 2018
Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
Journal: Journal of gastroenterology
Published: November 15, 2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.
Journal: The New England journal of medicine
Published: October 12, 2017
Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects.
Journal: Antimicrobial agents and chemotherapy
Published: October 03, 2017
Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
Journal: Journal of gastroenterology
Published: July 14, 2017
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
Journal: Journal of gastroenterology
Published: June 27, 2017
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.
Journal: Hepatology (Baltimore, Md.)
Published: June 23, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026